» Articles » PMID: 21423189

Delivery of SiRNA to the Mouse Brain by Systemic Injection of Targeted Exosomes

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2011 Mar 23
PMID 21423189
Citations 2111
Authors
Affiliations
Soon will be listed here.
Abstract

To realize the therapeutic potential of RNA drugs, efficient, tissue-specific and nonimmunogenic delivery technologies must be developed. Here we show that exosomes-endogenous nano-vesicles that transport RNAs and proteins-can deliver short interfering (si)RNA to the brain in mice. To reduce immunogenicity, we used self-derived dendritic cells for exosome production. Targeting was achieved by engineering the dendritic cells to express Lamp2b, an exosomal membrane protein, fused to the neuron-specific RVG peptide. Purified exosomes were loaded with exogenous siRNA by electroporation. Intravenously injected RVG-targeted exosomes delivered GAPDH siRNA specifically to neurons, microglia, oligodendrocytes in the brain, resulting in a specific gene knockdown. Pre-exposure to RVG exosomes did not attenuate knockdown, and non-specific uptake in other tissues was not observed. The therapeutic potential of exosome-mediated siRNA delivery was demonstrated by the strong mRNA (60%) and protein (62%) knockdown of BACE1, a therapeutic target in Alzheimer's disease, in wild-type mice.

Citing Articles

Prospect of extracellular vesicles in tumor immunotherapy.

Xia W, Tan Y, Liu Y, Xie N, Zhu H Front Immunol. 2025; 16:1525052.

PMID: 40078996 PMC: 11897508. DOI: 10.3389/fimmu.2025.1525052.


Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines.

Liu M, Wang Y, Zhang Y, Hu D, Tang L, Zhou B Signal Transduct Target Ther. 2025; 10(1):73.

PMID: 40059188 PMC: 11891339. DOI: 10.1038/s41392-024-02112-8.


Injured Cardiac Tissue-Targeted Delivery of TGFβ1 siRNA by FAP Aptamer-Functionalized Extracellular Vesicles Promotes Cardiac Repair.

Kang J, Mun D, Park M, Yoo G, Kim H, Yun N Int J Nanomedicine. 2025; 20:2575-2592.

PMID: 40046817 PMC: 11881639. DOI: 10.2147/IJN.S497428.


An anti-CD19-exosome delivery system navigates the blood-brain barrier for targeting of central nervous system lymphoma.

Zhao M, Li Q, Chai Y, Rong R, He L, Zhang Y J Nanobiotechnology. 2025; 23(1):173.

PMID: 40045315 PMC: 11881385. DOI: 10.1186/s12951-025-03238-9.


Current challenges surrounding exosome treatments.

Tzng E, Bayardo N, Yang P Extracell Vesicle. 2025; 2:100023.

PMID: 40027080 PMC: 11870656. DOI: 10.1016/j.vesic.2023.100023.


References
1.
Aguzzi A, OConnor T . Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov. 2010; 9(3):237-48. DOI: 10.1038/nrd3050. View

2.
Singer O, Marr R, Rockenstein E, Crews L, Coufal N, Gage F . Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005; 8(10):1343-9. DOI: 10.1038/nn1531. View

3.
Laird F, Cai H, Savonenko A, Farah M, He K, Melnikova T . BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci. 2005; 25(50):11693-709. PMC: 2564291. DOI: 10.1523/JNEUROSCI.2766-05.2005. View

4.
Thery C, Amigorena S, Raposo G, Clayton A . Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2008; Chapter 3:Unit 3.22. DOI: 10.1002/0471143030.cb0322s30. View

5.
Simhadri V, Reiners K, Hansen H, Topolar D, Simhadri V, Nohroudi K . Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One. 2008; 3(10):e3377. PMC: 2566590. DOI: 10.1371/journal.pone.0003377. View